Delaying Parkinson’s Diseas ( A new study shows anti-inflammatory dru...)

Delaying Parkinson’s Diseas

A new study shows anti-inflammatory drugs do prevent the onset of Parkinson’s disease. The study, led by Harvard researchers, shows people who regularly take nonsteroidal// anti-inflammatory drugs (NSAIDs) had a lower risk of Parkinson’s than those who did not take the drugs.

Parkinson’s disease is characterized by the death of neurons in the brain. The result is a loss in motor function. Some NSAIDs appear to be protective in animal studies and they also are shown to reduce the risk of Alzheimer’s disease in humans. This study looked at the results of two previous studies.

The two studies involved nearly 145,000 men and women. All were free of Parkinson’s disease, stroke, and cancer. About 6 percent of men and nearly 4 percent of women reported regular use of NSAIDs. During the follow-up time period, 415 cases of PD were reported. Participants who reported regular use of NSAIDs at the beginning of the study had about a 45-percent lower risk of developing PD than non-regular users.

In an accompanying editorial, Mya Schiess, M.D., from the University of Texas-Houston Medical School, points out the merits and drawbacks of the study. Dr. Schiess says this study indicates a strong positive benefit of NSAIDs, however it is not yet known what the danger level would be for gastrointestinal bleeding and kidney faiure.

Page: 1
Related medicine news :

1. Delaying The Progression Of Alzheimer’s Disease
2. The Effects Of Delaying A Delivery Questioned
3. Delaying pregnancy may lessen life expectancy of the child
4. UK Facing Shortage of Radiotherapists Delaying Cancer Treatment
5. Delaying Hernia Surgery Is Considered A Safe Option
6. NPIL withdraws Parkinson’s dru
7. Parkinson’s Drug Linked to Gamblin
8. New Drug For Parkinson’s Disease With Less Side Effect
9. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
10. Magnetic Stimulation For Parkinson’s Diseas
11. Exercising regularly can reduce the risk of Parkinson’s diseas

Post Your Comments:

(Date:12/4/2008)...er 4, 2008) - An Ontario study of 491 women with ...ion, 19%, were referred for genetic testing of BRC... family members are not informed of their cancer r...or at the University of Toronto,s Lawrence S. Bloo... at Women,s College Research Institute, led the nu...

(Date:12/4/2008)... Reawakening a dormant gene could ease sick... (Vocus) December 4, 2008 -- Researchers a...al.org ) and Dana-Farber Cancer Institute have ide...form of hemoglobin normally made only before birth...form sickle-cell disease and beta-thalassemia -- l...

(Date:12/4/2008)...Dec. 4 NAMC members can gain acces...desktop. Webinars feature nationally-recognized sp...ter. The next webinar will be on December 10, 200...e Audience , Do you know where your online infl..., do you know how to engage them? , This webin...

(Date:12/4/2008)... Dr. Stephen Joffe, Craig Joffe, a...Schedule 13D with the U.S.,Securities and Exchang...isclosing ownership of 11.4% of LCA-Vision, Inc. (...ed-site laser vision correction centers in 33 stat...r and former Chairman and CEO of,LCAV. Craig Jof...

[0] Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes [0] Turning back the Clock in Inherited Anemias [0] New NAMC Member Service! Complimentary Webinars for NAMC Members - On Topics You Need to Know! Sign Up Today for This New and Exciting Educational Program![0] 11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions

...r Disease Control and Prevention (CDC) shows that ...ve among teenagers.// The CDC defines binge drin..." and the National Institute of Alcohol Abuse and ...attern of drinking that brings a person’s blood al...

...the US the present guidelines should be modified a...rnal of Respiratory and// Critical Care Medicine. ...fied as "high-risk,” when they have originally com...This paper has been published by American Thoracic...

...ring during the winter cold and flu season//, a vo...alth System is offering tips for preventing and tr...e of voice change that can accompany the common co... something that is quite common, and I’m sure most...

...lung function who later develop chronic cough and ... chronic obstructive pulmonary disease (COPD). The...in the first issue for January 2007 of the America... Care Medicine, published by the American Thoracic...

Other Medicine News:Health News:TB can Be Eradicated in the U.S With Modified Guidelines: Study 2 Health News:Tips to Prevent and Treat Winter Laryngitis 2 Health News:Cough and Phlegm Cause Fourfold Increase in COPD Incidence 2

Binge Drinkers on the Rise TB can Be Eradicated in the U.S With Modified Guidelines: Study Tips to Prevent and Treat Winter Laryngitis Cough and Phlegm Cause Fourfold Increase in COPD Incidence

(Date:12/3/2008)... NEWARK, Del., Dec. 3 Isogen, a c...n for sterile filling, announced it has retained a...erations to meet the global,biopharma demand for ...announced a successful first round series of capit...g line facility in Q1 2009 to,deliver on the prev...

(Date:12/2/2008)... CHICAGO, Dec. 3 Breas...he detection of cancers not found on mammograms or... today at the annual meeting of,the Radiological ...n identify the most difficult to detect breast can... Rachel F. Brem, M.D., professor of,radiology and...

(Date:12/2/2008)... BETHESDA, Md., Dec. 2 ...cal company developing novel, proprietary antibodi...utoimmune diseases, today announced that it has en...uity Financing Facility (CEFF) with Kingsbridge Ca...the terms of the agreement, Kingsbridge has commit...

(Date:12/1/2008)... SINGAPORE, Dec. 1 S*BIO Pte Ltd ...ical trial of SB1518, a potent and orally-active J...alia for patients with chronic idiopathic myelofib... evaluate the safety and tolerability of SB1518 in... 50 patients. The Phase 1 part of the study will ...

Breaking Medicine Technology:Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2 Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3 New Breast Imaging Technology Targets Hard-to-Detect Cancers 2 New Breast Imaging Technology Targets Hard-to-Detect Cancers 3 Micromet Expands Committed Equity Financing Facility to $75 Million 2 Micromet Expands Committed Equity Financing Facility to $75 Million 3 Micromet Expands Committed Equity Financing Facility to $75 Million 4 Micromet Expands Committed Equity Financing Facility to $75 Million 5 Micromet Expands Committed Equity Financing Facility to $75 Million 6 S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2 S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3 Ron Greenspan DDS Creates Plan to Eliminate the Barriers to Orthodontic Treatment 23999 1 Ron Greenspan DDS Creates Plan to Eliminate the Barriers to Orthodontic Treatment 23999 2 AMT Starts Collaboration With St Jude Childrens Research Hospital on Gene Therapy for Hemophilia B Company Accesses Exclusive Commercial Rights to F 6542 1 AMT Starts Collaboration With St Jude Childrens Research Hospital on Gene Therapy for Hemophilia B Company Accesses Exclusive Commercial Rights to F 6542 2 AMT Starts Collaboration With St Jude Childrens Research Hospital on Gene Therapy for Hemophilia B Company Accesses Exclusive Commercial Rights to F 6542 3 AMT Starts Collaboration With St Jude Childrens Research Hospital on Gene Therapy for Hemophilia B Company Accesses Exclusive Commercial Rights to F 6542 4 Aggressive preschoolers found to have fewer friends than others 23995 1 Aggressive preschoolers found to have fewer friends than others 23995 2 Culture and depression 23992 1 Culture and depression 23992 2

[0] Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand [0] New Breast Imaging Technology Targets Hard-to-Detect Cancers [0] Micromet Expands Committed Equity Financing Facility to $75 Million [0] S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis

...wire/ -- Phase 3 results,from the RE-NOVATE(TM) tr...ce daily, administered for an average of 33 days, ...for an average of 33,days, in preventing venous th...total hip replacement surgery. In this trial, the,...etexilate was,similar to enoxaparin. The incidence...

...oper Antisoma plc,(LSE: ASM, US OTC: ATSMY) today ...04 in recurrent, platinum-sensitive ovarian cancer...us chemotherapy,(n=37) with patients receiving che...ollows: , * There was no advantage in median time ...ith the control arm * One-year survival,rates were...

Other Medicine Technology:Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4 Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5 Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 2 Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial 3

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial

Each ENDOKNOT™ consists of a 42" long suture inserted into a plastic tube. The plastic tube is narrow at one end and scored on the other. The suture protrudes from the narrow end and swaged to

The ENDOLOOP consists of 18'' long ligature inserted into a plastic tube. The plastic tube is narrow at one end and scored on the other. The suture protrudes from the narrow end and is formed in a li

...201+ is the latest addition to the HemoCue glucose...new system combines the precision and accuracy of ...time and ease of use. The new pocket size analyser... date and time for up to 600 measurements. The sto...

Medicine Products:

ENDOKNOT Suture Type - 2-0 Chromic Gut Suture ENDOLOOP Ligature Type - 0 Plain Gut ligature ENDOLOOP Ligature Type - 0 Chromic Gut HemoCue 201+ systems, Hb

( A new study shows anti-inflammatory dru...)Delaying Parkinson’s Diseas,Health